Avidity Partners Management as of March 31, 2026
Portfolio Holdings for Avidity Partners Management
Avidity Partners Management holds 46 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Dianthus Therapeutics (DNTH) | 41.8 | $185M | 2.1M | 87.80 | |
| Oruka Therapeutics (ORKA) | 11.8 | $52M | 760k | 68.41 | |
| Jade Biosciences Com New (JBIO) | 7.7 | $34M | 1.4M | 24.40 | |
| Perspective Therapeutics Com New (CATX) | 5.3 | $24M | 6.0M | 3.90 | |
| Enliven Therapeutics (ELVN) | 3.7 | $17M | 400k | 41.23 | |
| Context Therapeutics (CNTX) | 2.7 | $12M | 5.0M | 2.36 | |
| Repligen Corporation (RGEN) | 2.1 | $9.2M | 78k | 118.31 | |
| Palvella Therapeutics Inc Ne (PVLA) | 2.0 | $9.0M | 70k | 128.32 | |
| Aktis Oncology | 2.0 | $8.8M | 469k | 18.75 | |
| Medtronic SHS (MDT) | 1.8 | $8.1M | 100k | 80.97 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 1.6 | $7.0M | 200k | 35.07 | |
| Immunic (IMUX) | 1.5 | $6.4M | 670k | 9.62 | |
| Vir Biotechnology (VIR) | 1.4 | $6.3M | 619k | 10.21 | |
| Dex (DXCM) | 1.3 | $6.0M | 100k | 59.55 | |
| Humana (HUM) | 1.3 | $5.9M | 25k | 236.44 | |
| Encompass Health Corp (EHC) | 1.0 | $4.2M | 42k | 100.00 | |
| Karyopharm Therapeutics Com New (KPTI) | 0.9 | $3.9M | 464k | 8.31 | |
| Tempus Ai Cl A (TEM) | 0.8 | $3.6M | 65k | 55.48 | |
| Tenax Therapeutics Com New (TENX) | 0.8 | $3.5M | 266k | 13.11 | |
| Boston Scientific Corporation (BSX) | 0.8 | $3.5M | 60k | 57.61 | |
| Satellos Bioscience | 0.7 | $3.1M | 388k | 7.95 | |
| Phathom Pharmaceuticals (PHAT) | 0.6 | $2.8M | 249k | 11.20 | |
| Gilead Sciences (GILD) | 0.6 | $2.6M | 20k | 130.84 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.5 | $2.0M | 48k | 41.45 | |
| Scynexis Com New (SCYX) | 0.4 | $1.9M | 2.1M | 0.93 | |
| Icon SHS (ICLR) | 0.4 | $1.9M | 16k | 118.33 | |
| Natera (NTRA) | 0.4 | $1.9M | 9.0k | 206.16 | |
| Corvus Pharmaceuticals (CRVS) | 0.4 | $1.7M | 115k | 15.19 | |
| Insulet Corporation (PODD) | 0.4 | $1.7M | 10k | 172.14 | |
| Charles River Laboratories (CRL) | 0.4 | $1.7M | 10k | 166.97 | |
| Corcept Therapeutics Incorporated (CORT) | 0.3 | $1.4M | 30k | 46.52 | |
| Hims & Hers Health Com Cl A (HIMS) | 0.3 | $1.4M | 50k | 27.17 | |
| Genmab A/s Sponsored Ads (GMAB) | 0.3 | $1.3M | 50k | 26.52 | |
| Peloton Interactive Cl A Com (PTON) | 0.2 | $1.1M | 200k | 5.45 | |
| Intellia Therapeutics (NTLA) | 0.2 | $1.0M | 75k | 13.48 | |
| Oddity Tech Shs Cl A (ODD) | 0.2 | $1.0M | 70k | 14.32 | |
| Anteris Technologies Global (AVR) | 0.2 | $923k | 150k | 6.15 | |
| Abbott Laboratories (ABT) | 0.2 | $908k | 10k | 90.79 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.2 | $819k | 50k | 16.38 | |
| Bridgebio Pharma (BBIO) | 0.2 | $711k | 10k | 71.11 | |
| Arbutus Biopharma (ABUS) | 0.1 | $525k | 125k | 4.20 | |
| Bridgebio Oncology Therapeut Com New (BBOT) | 0.1 | $369k | 44k | 8.41 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.1 | $353k | 15k | 23.52 | |
| ACADIA Pharmaceuticals (ACAD) | 0.1 | $291k | 13k | 22.45 | |
| Savara (SVRA) | 0.1 | $262k | 50k | 5.24 | |
| Trevi Therapeutics (TRVI) | 0.0 | $92k | 6.7k | 13.76 |
